Search

Search bills, members, committees and pages...

S. 3011

U.S. SenateIn Senate Committee

Summary

S. 3011, the Prohibiting Abortion & Transgender Procedures on the Exchanges Act, was introduced in the Senate on Oct 15, 2025 by Sen. Josh Hawley (R). It was referred to Health, Education, Labor, And Pensions, and last saw action on Oct 15, 2025: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.


Record

Text

S. 3011 has no co-sponsors and has not gone to a roll call.

sb3011/introduced-in-senate.txt
119 S3011 IS: To amend the Patient Protection and Affordable Care Act to exclude coverage of gender-transition procedures for minors and abortion under health plans offered through the American Health Benefits Exchanges, and for other purposes.
U.S. Senate
2025-10-15
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
II
119th CONGRESS
1st Session
S. 3011
IN THE SENATE OF THE UNITED STATES
October 15, 2025
Mr. Hawley introduced the following bill;
which was read twice and referred to the Committee on Health, Education, Labor, and
Pensions
A BILL
To amend the Patient Protection and Affordable Care Act to exclude coverage
of gender-transition procedures for minors and abortion under health plans offered
through the American Health Benefits Exchanges, and for other purposes.
1.
Short title
This Act may be cited as the Prohibiting Abortion & Transgender Procedures on the Exchanges Act .
2.
Exclusion of gender-transition procedures for minors and abortion from coverage
under health plans offered through the American Health Benefits Exchanges
(a)
In general
Section 1303 of the Patient Protection and Affordable Care Act ( 42 U.S.C. 18023 ) is amended—
(1)
in subsection (a)—
(A)
by striking paragraph (2); and
(B)
by striking the subsection designation and heading and all that follows through A State in paragraph (1) and inserting the following:
(a)
State opt-Out of abortion coverage
A State
;
(2)
in subsection (b), by striking the subsection designation and heading and all that follows through No qualified in paragraph (4) and inserting the following:
(b)
No discrimination on basis of provision of abortion
No qualified
;
(3)
in subsection (c)—
(A)
in paragraph (2)—
(i)
by striking the paragraph designation and heading and all that follows through Nothing in subparagraph (A) and inserting the following:
(2)
No effect on Federal laws regarding abortion
Nothing
; and
(ii)
by redesignating clauses (i) through (iii) as subparagraphs (A) through (C), respectively, and adjusting the margins accordingly;
(B)
by striking the subsection designation and heading and all that follows through the end of paragraph (1) and inserting the following:
(c)
Application of Federal laws
; and
(C)
by redesignating paragraphs (2) and (3) as paragraphs (1) and (2), respectively;
(4)
by redesignating subsections (a) through (d) as subsections (b) through (e), respectively; and
(5)
by inserting before subsection (b) (as so redesignated) the following:
(a)
Prohibition on coverage of gender-Transition procedures for
minors and abortion
(1)
In general
An Exchange may not make available any health plan, including any health plan offering excepted benefits (as defined in section 2791(c) of the Public Health Service Act), that provides coverage for—
(A)
abortion, except in the case where a woman suffers from a physical disorder, physical injury, or physical illness that would, as certified by a physician, place the woman in danger of death unless an abortion is performed, including a life-endangering physical condition caused by or arising from the pregnancy itself, or unless the pregnancy is the result of an act of rape or incest; or
(B)
gender-transition procedures for minors.
(2)
Definitions
In this subsection:
(A)
Gender-transition procedure
(i)
In general
Except as provided in clause (ii), the term gender-transition procedure means—
(I)
the prescription or administration of gonadotropin-releasing hormone agonists or any other puberty-blocking drugs for the purpose of changing the body of an individual so that it conforms to the subjective sense of identity of the individual, in the case such identity is at odds with the individual's biological sex of male or female;
(II)
the prescription or administration of testosterone (when prescribed to a female) or estrogen (when prescribed to a male) for the purpose of changing the body of an individual so that it conforms to the subjective sense of identity of the individual, in the case such identity is at odds with the individual’s biological sex of male or female; or
(III)
a surgery to change the body of an individual so that it conforms to the subjective sense of identity of the individual, in the case such identity is at odds with the individual’s biological sex of male or female.
(ii)
Exception
The term gender-transition procedure does not include—
(I)
an intervention described in clause (i) that is performed on—
(aa)
an individual with biological sex characteristics that are inherently ambiguous, such as those born with 46 XX chromosomes with virilization, 46 XY chromosomes with undervirilization, or having both ovarian and testicular tissue; or
(bb)
an individual with respect to whom a physician has determined through genetic or biochemical testing that the individual does not have normal sex chromosome structure, sex steroid hormone production, or sex steroid hormone action, for a biological male or biological female;
(II)
the treatment of any infection, injury, disease, or disorder that has been caused or exacerbated by the performance of an intervention described in clause (i) without regard to whether the intervention was performed in accordance with State or Federal law; or
(III)
any procedure undertaken because the individual suffers from a physical disorder, physical injury, or physical illness that would, as certified by a physician, place the individual in imminent danger of death or impairment of major bodily function unless the procedure is performed.
(B)
Minor
The term minor means an individual who has not yet reached 18 years of age.
.
(b)
Conforming amendment
Section 1334(a) ( 42 U.S.C. 18054(a) ) is amended—
(1)
by striking paragraph (6); and
(2)
by redesignating paragraph (7) as paragraph (6).
(c)
Effective date
The amendments made by this section shall apply with respect to plan years beginning on or after January 1, 2026.

Tracker

The tracker indicates the progress of this legislation as it moves through the legislative process.

  1. Introduced2025-10-15
  2. Passed Senate
  3. Passed House
  4. Conference
  5. To President
  6. Became Law

A bill to amend the Patient Protection and Affordable Care Act to exclude coverage of gender-transition procedures for minors and abortion under health plans offered through the American Health Benefits Exchanges, and for other purposes.

Sponsors

Sen. Josh Hawley (R) sponsors S. 3011 alone.

Committees

S. 3011 went before 1 committee: Health, Education, Labor, and Pensions.

Health, Education, Labor, and Pensions
Health, Education, Labor, and Pensions
Referred To · Oct 15, 2025 · 747 Bills

Actions

S. 3011 has taken 2 actions since Oct 15, 2025.

ChamberAction
Oct 15, 2025
Senate
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.Health, Education, Labor, and Pensions Committee
Oct 15, 2025
Introduced in Senate

Votes

S. 3011 has not gone to a roll call.

Titles

S. 3011 goes by 3 titles, 1 of them short titles.

  • Prohibiting Abortion & Transgender Procedures on the Exchanges Act — Display Title
  • Prohibiting Abortion & Transgender Procedures on the Exchanges Act — Short Title(s) as Introduced
  • A bill to amend the Patient Protection and Affordable Care Act to exclude coverage of gender-transition procedures for minors and abortion under health plans offered through the American Health Benefits Exchanges, and for other purposes. — Official Title as Introduced

Lobbying

2 clients hired 2 firms and 11 registered lobbyists who named S. 3011 in 4 quarterly filings, 2025 to 2026. Reported under the Lobbying Disclosure Act; a filing’s income covers everything its registrant worked that quarter, so the amounts below are the filings’, not this bill’s.

Filed under Civil Rights/Civil Liberties, Defense, Education, Family issues/Abortion/Adoption, Foreign Relations, Health Issues, Immigration, Law Enforcement/Crime/Criminal Justice.

Clients

Who paid to be heard, by how many filings named the bill.

ClientBusinessStateFirmsFilingsReported
HUMAN RIGHTS CAMPAIGNDistrict of Columbia13
SUSAN B ANTHONY LISTVirginia11

Firms

Registrants who filed on the bill, by filings.

RegistrantClientsFilingsReported
HUMAN RIGHTS CAMPAIGN13
SUSAN B ANTHONY LIST11

Lobbyists

Named on the filings that cite the bill.

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, largest reported first.

ClientRegistrantPeriodReportedDocument
SUSAN B ANTHONY LISTSUSAN B ANTHONY LIST2025 fourth_quarter$420K4th Quarter - Report
HUMAN RIGHTS CAMPAIGNHUMAN RIGHTS CAMPAIGN2026 second_quarter$223.7K2nd Quarter - Report
HUMAN RIGHTS CAMPAIGNHUMAN RIGHTS CAMPAIGN2025 fourth_quarter$216.2K4th Quarter - Report
HUMAN RIGHTS CAMPAIGNHUMAN RIGHTS CAMPAIGN2026 first_quarter$174.3K1st Quarter - Report

Classification

The Congressional Research Service files S. 3011 under Health, one of its 31 policy areas.

CRS Subjects

CRS assigns every bill one policy area from its 31; S. 3011’s is Health.

s3011/policy-areas.txt
HealthAgriculture and FoodAnimalsArmed Forces and National SecurityArts, Culture, ReligionCivil Rights and Liberties, Minority IssuesCommerceCongressCrime and Law EnforcementEconomics and Public FinanceEducationEmergency ManagementEnergyEnvironmental ProtectionFamiliesFinance and Financial SectorForeign Trade and International FinanceGovernment Operations and PoliticsHousing and Community DevelopmentImmigrationInternational AffairsLabor and EmploymentLawNative AmericansPublic Lands and Natural ResourcesScience, Technology, CommunicationsSocial WelfareSports and RecreationTaxationTransportation and Public WorksWater Resources Development

Source: congress.gov · legiscan.com